Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +75.3% | +123.2% | 3 / 3 | +1.1% | +1.27 pp | +0.17 pp | +6.8% | 0.77 | 6.38 | 670 | +1,1% | 2,8 | +75,3% | 6.38 | 14.06 | −54,6% |
| Pts | 12 | 12 | 12 | 0 | 8 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 8.000 (close price on 2026-10-19)EPS (TTM): 1.255
Financial charts
1.Revenue & growth
VND bn670Q3/26
1.Revenue & growth
VND bn670Q3/26
2.Profit & growth
VND bn2,77Q3/26
3.Profit mix (Penman)
VND bn19,2Q3/26
4.Margins & cost structure
%3.6%Q3/26
5.Returns & cash cycle
% · days7.0%Q3/26
6.Earnings quality & cash
VND bn-90,1Q3/26
7.Asset structure
VND bn670Q3/26
8.Funding & debt health
VND bn · times670Q3/26
9.Revenue backlog
VND bn0,00Q3/26
10.Valuation
times · %6,4×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %226Q3/26
Adjusted EPS growth, latest quarter
75.3%
Average adjusted EPS growth, 3 quarters
123%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26